Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation

References

• Miechie HR, Manogue KR, Spriggs DR, Revhaugh A, O'Dwyer S, Dinarello SA, et al. Detection of circulating tumour necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481–6
   PubMed Web of Science ®Google Scholar
• Marrack P, Kappler I. The staphylococcal enterotoxins and their relations. Science 1990; 248: 247–9
   Web of Science ®Google Scholar
• Keroack MA. lnvasive group A streptococcal infection and streptococcal toxic shock syndrome. Curr Opin Inf Dis 1991; 4: 621–7
   Web of Science ®Google Scholar
• Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxin shock syndrome and related illness. Microbiology 1989; 17: 251–7
   Web of Science ®Google Scholar
• Musser JM, Mauser AR, Kiow HM, Schlievert PM, Nelson K, Selander RK. Streptococcus pyog-enus causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyogenic exotoxin expression. Proc Natl Acad Sci USA 1991; 88: 2668–72
   PubMed Web of Science ®Google Scholar
• Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229: 869–71
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44: 153–205
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. An interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550–2
   PubMed Web of Science ®Google Scholar
• Björk P, Ohlsson K. The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse. Mediators of Inflammation 1992; 1: 27–31
   PubMedGoogle Scholar
• Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167–227
   PubMed Web of Science ®Google Scholar
• Olsson I, Lam M, Nilsson E, Peetre H, Thysell H, Grubb A. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989; 42: 270–5
   PubMed Web of Science ®Google Scholar
• Ulich TR, Guo K, Yin S, del Castillio J, Yi ES, Thompson RC, et al. Endotoxin-induced cytokine gene exoressionin vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol 1992; 141: 61–8
   PubMed Web of Science ®Google Scholar
• Jansson RW, Hance KH, Arend WP. Production of IL-1 receptor antagonist by humanin vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 1991; 147: 4218–223
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem 1974; 42: 519–27
   PubMedGoogle Scholar
• Ohlsson K, Linder C, Rosengren M. Monoclonal antibodies specific for neutrophil proteinase 4. Production and use for isolation of the enzyme. Biol Chem Hoppe-Zeyler 1990; 371: 549–55
   PubMed Web of Science ®Google Scholar
• Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radio-iodinated protein A. Analyt Biochem 1981; 112: 195–203
   PubMed Web of Science ®Google Scholar
• Scheidegger JJ. Une micro-méthode de I'immunoe-lectrophoresis. Int Arch Allergy 1955; 7: 103–9
   Web of Science ®Google Scholar
• Ouchterlony Ö. In vitromethod for testing the toxin-producing capacity of diphteria bacteria. Acta Pathol Microbiol 1948; 25: 186–90
   PubMedGoogle Scholar
• Bergenfeldt M, Axelsson L, Ohlsson K. Release of neutrophil proteinase 4(3) and leuwyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 1992; 52: 823–9
   PubMed Web of Science ®Google Scholar
• Bergenfeldt M, Ohlsson K. Protease-antiprotease levels and whole-blood chemiluminiscence in acute peritonitis. Gastroenterol Japon 1993; 28: 687–98
   PubMedGoogle Scholar
• Oblsson K, Olsson I. The extracellular release of granulocyte collagenase and elastase during phagocytosis and intlammatory processes. Scand J Haematol 1977; 19: 145–52
   PubMedGoogle Scholar
• Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete TNF alpha. Proc Nat Acad Sci USA 1990; 87: 6758–61
   PubMed Web of Science ®Google Scholar
• Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768–74
   PubMed Web of Science ®Google Scholar
• Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immuno 1992; 22: 2617–23
   PubMed Web of Science ®Google Scholar
• Marucha PT, Zeff RA, Kreutzer DL. Cytokine regulation of IL-1 gene expression in human poly-morphonuclear leukocyte. J Immunol 1990; 145: 2932–7
   PubMed Web of Science ®Google Scholar